Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Seizure, Surgery
Clinical narrative: lupus/autoimmune injuries/ fatigue/ pain in her joints; muscle spasm/ pan in her muscle/ fibromyalgia/brain fog/ chronic fatigue/chronic fatigue and pain; pain in her joints/ psoriatic arthritis; anemia/fatigue; dysmenorrhea; cyst on her ovaries; three separate miscarriages; seizures; infertility; the patient sustained serious autoimmune and neurological injuries; irritable bowel syndrome/gastrointestinal pain; chronic migraine; This retrospective pregnancy report has been received from a lawyer regarding a case in litigation and refers to a female patient of an unknown age. The patient was healthy, physically active, and athletic. Her concurrent conditions, medical history and concomitant therapies were not provided. On an unknown date, reported as at the age of 14 years old, the patient was vaccinated with the first dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (dose, route of administration, anatomical location, lot# and expiration date were not reported) for prophylaxis as recommended by physician assistant. On an unknown date, she was administered the second dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (dose, route of administration, anatomical location, lot# and expiration date were not reported) for prophylaxis as recommended by physician assistant. On an unknown date, the patient received the third dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (dose, route of administration, anatomical location, lot# and expiration date were not reported) for prophylaxis as recommended by physician assistant. The patient sustained serious autoimmune and neurological injuries as a result of her Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) injections. On an unknown date, reported as after receiving Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL), the patient experienced pain in her joints, muscle spasms, brain fog, and chronic fatigue which she at first attributed to over-exertion and physical activity. She also experienced gastrointestinal pain, chronic migraines, seizures, dysmenorrhea and a cyst on her ovaries. She was seen by multiple physicians and specialists for her complaints and underwent three surgeries (no details provided). On an unknown date, the patient became pregnant. The last menstrual period (LMP) and estimated delivery date (EDD) was not reported. The pregnancy outcome was spontaneous abortion. She suffered three separate miscarriages (two early in pregnancy and one at four months). The first time she discovered that her injuries could had been caused by the vaccine was in February 2021. As a result of her post-Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) symptoms, the patient had been unable to engage in activities that a young person her age would normally enjoy. She suffered chronic fatigue and pain which made it difficult to function. Her college performance suffered because of her symptoms, and she was uncertain whether she will ever be able to have children of her own. ased upon her chronic and severe post-Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL)symptoms, she was diagnosed with various medical conditions, including but not limited to, fibromyalgia, chronic migraine, chronic fatigue, lupus, psoriatic arthritis, anemia, and irritable bowel syndrome. She contended that her Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL)injections caused her to develop serious and debilitating autoimmune and neurological, injuries, including but not limited to fibromyalgia, chronic migraine, chronic fatigue, lupus, psoriatic arthritis, anemia, irritable bowel syndrome, and infertility, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which were alleged and all of which were caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) or otherwise linked to her Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL)-induced autoimmune disorder. As a proximate result of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL), the patient suffered and continued to suffer severe and permanent physical injuries, and associated symptomology and suffered severe and permanent emotional injuries, including pain and suffering. She also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL). As a direct and proximate result of her Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL)-induced injuries, she suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and she would continue to incur these losses and expenses in the future. The outcome of the events was considered to be not recovered. The reporter considered the events to be related to Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL).   All the events were considered as disabling. Upon internal review, the events of seizure, lupus, psoriatic arthritis and miscarriages were considered to be medically significant.